-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Ambrx Biopharma Cayman, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2022 to 2023.
- Ambrx Biopharma Cayman, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2023 was $29.6 M.
- Ambrx Biopharma Cayman, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$46.7 M, a 1357% decline from 2021.
- Ambrx Biopharma Cayman, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$3.21 M, a 1172% decline from 2020.
- Ambrx Biopharma Cayman, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2020 was -$252 K, a 425% decline from 2019.